Cancer is a major public health burden in both developed and developing countries. Plant-derived compounds have played an important role in the development of useful anti-cancer agents. The current study was designed to evaluate the cytotoxic activity of chemical compounds from the stem bark of Styrax obassia. Seven known compounds (1−7) were isolated and identified. Compound 2 exhibited cytotoxic activity against the breast cancer cell line MCF-7 with an IC 50 of 27.9 µM, followed by the human cervical cancer cell line Hela with an IC 50 of 23.3 µM, and the human promyelocytic leukemia cell line HL-60 with an IC 50 of 47.8 µM. Compound 7 exhibited cytotoxicity against Hela cells with an IC 50 of 16.8 µM, followed by MCF-7 cells with an IC 50 of 53.5 µM. This is the first study to investigate the significant anti-tumor properties of isolated compounds from the stem bark of S. obassia. Chemical investigation of the bark of S. obassia using efficient separation techniques led to the isolation of seven compounds (1−7), which were identified as 1"-hydroxylegonol gentiobioside (1), egonol glucoside (2), syringin (3) The seven isolated compounds (1−7) were tested for cytotoxic activity against MCF-7, Hela, and HL-60 cell lines. In the cytotoxic assay using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay according to Mosmann [3a] with adriamycin as the positive control, compound 2 revealed cytotoxic activities against MCF-7, Hela, and HL-60 cell lines with IC 50 values of 27.9 + 1.6, 23.3 + 2.8, and 47.8 + 2.5 µM, respectively. Compound 7 was inactive against HL-60, but displayed weak cytotoxic activity against MCF-7 and Hela cell lines with IC 50 values of 53.5 + 2.6 and 16.8 + 1.0 µM, respectively, while the other compounds exhibited no cytotoxic activity. In comparison, adriamycin gave IC 50 values of 7.7 + 1.9, 0.61 + 0.01 and 0.10 + 0.01 µM, respectively. From the data, it seems that the benzofuran lignan and the flavonoid skeletons are essential for cytotoxic activity [3b,3c]. In addition, compound 1 is a benzofuran derivative, but showed no cytotoxic activity against MCF-7, Hela, and HL-60 cells (IC 50 > 100 µM). The structure of compound 1 differs from that of 2 by more than one glycosyl group. The results suggest that more than one glycosyl group caused a decrease in cytotoxic activity against all cancer cell lines. Compound 7 has a free hydroxyl group at position 3 and a para-hydroxyl group in ring B, which probably increases the activity of this compound [3d]. Thus, this compound could be a useful anticancer agent. Unfortunately, the cytotoxic activity of all isolated compounds was less than that of the positive control.
Styrax is by far the largest genus in Styracaceae, which is a family of small trees and shrubs indigenous to tropical and subtropical regions. Chemical investigations into several Styrax species have revealed them to be rich sources of egonol, benzofurans, benzofuran glycosides, saponins, and triterpenoids [1a-1e] . Styrax species have been shown to have a variety of biological activities including insecticidal, fungicidal, antimicrobial, antidiabetic, antiproliferative, cytotoxic, and antioxidant [1f,1g] . Phytochemical studies have reported the presence of egonol derivatives in S. obassia extracts [1a, 1h, 1i] . Furthermore, S. obassia isolates have been found to exhibit inhibitory effects on nitric oxide (NO) production [1j].
Chemical investigation of the bark of S. obassia using efficient separation techniques led to the isolation of seven compounds (1−7), which were identified as 1"-hydroxylegonol gentiobioside (1), egonol glucoside (2), syringin (3), (+)-1-hydroxylpinoresinol-4'-β-D-glucoside (4), pinoresinol-4'-O-β-D-glucoside (5), (−)-lariciresinol 4'-(6"-O-feruloyl-β-D-glucopyranoside) (6), and castanoside B (7) by comparing their physicochemical and spectroscopic data with those reported in the literature [2a-2g] . Compound 7 was isolated from a Styrax species for the first time (Figure 1 ).
The seven isolated compounds (1−7) were tested for cytotoxic activity against MCF-7, Hela, and HL-60 cell lines. In the cytotoxic assay using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay according to Mosmann [3a] with adriamycin as the positive control, compound 2 revealed cytotoxic activities against MCF-7, Hela, and HL-60 cell lines with IC 50 values of 27.9 + 1.6, 23.3 + 2.8, and 47.8 + 2.5 µM, respectively. Compound 7 was inactive against HL-60, but displayed weak cytotoxic activity against MCF-7 and Hela cell lines with IC 50 values of 53.5 + 2.6 and 16.8 + 1.0 µM, respectively, while the other compounds exhibited no cytotoxic activity. In comparison, adriamycin gave IC 50 values of 7.7 + 1.9, 0.61 + 0.01 and 0.10 + 0.01 µM, respectively. From the data, it seems that the benzofuran lignan and the flavonoid skeletons are essential for cytotoxic activity [3b,3c] . In addition, compound 1 is a benzofuran derivative, but showed no cytotoxic activity against MCF-7, Hela, and HL-60 cells (IC 50 > 100 µM). The structure of compound 1 differs from that of 2 by more than one glycosyl group. The results suggest that more than one glycosyl group caused a decrease in cytotoxic activity against all cancer cell lines. Compound 7 has a free hydroxyl group at position 3 and a para-hydroxyl group in ring B, which probably increases the activity of this compound [3d]. Thus, this compound could be a useful anticancer agent. Unfortunately, the cytotoxic activity of all isolated compounds was less than that of the positive control.
Natural Product Communications
under reduced pressure, the crude MeOH extract (130 g) was obtained and suspended in hot water and partitioned with n-hexane, CHCl 3 , EtOAc, and H 2 O, successively, to afford n-hexane (53 g), CHCl 3 (35 g), EtOAc (6 g), and H 2 O (35 g) soluble fractions, respectively. The EtOAc-soluble fraction (6.0 g) was subjected to a silica gel column with CHCl 3 -MeOH (30:1→8:2) as eluents to acquire 12 fractions (E1 ~ E12). Fraction E7 (270.3 mg) was applied to a RP-C 18 silica gel column and eluted with MeOH-H 2 O (1:2) to obtain compound 2 (15.6 mg). Fraction E10 (521.7 mg) was applied to an RP-C 18 silica gel column and eluted with MeOH-H 2 O (1:3 → 2:5) to afford 19 sub-fractions (E10.1 ~ E10.19). Compound 5 (80.0 mg) was obtained from sub-fraction E10.2 (100.0 mg) by RP-C 18 silica gel CC with MeOH-H 2 O (1:3). Sub-fraction E10.9 (100.0 mg) was purified by high-performance liquid chromatography (HPLC) [eluted with a gradient solvent system of MeOH-H 2 O (50:50 → 65:35) over 60 min; flow rate: 3 mL/min; UV detection at 210 nm; an YMC-Pack ODS-A, 250 × 20 mm column] to obtain compound 6 (4.8 mg, t R = 36 min). Compound 7 (13.5 mg, t R = 30 min) was obtained by HPLC [eluted with MeOH-H 2 O (55:45 → 65:35) over 60 min; flow rate: 3 mL/min; UV detection at 210 nm] from sub-fraction E10.18 (97.3 mg). Fraction E12 (500.0 mg) was applied to an RP-C 18 silica gel column and eluted with MeOH-H 2 O (1:3 → 1:1) to afford compound 1 (200.0 mg) and 8 sub-fractions (E12.1 ~ E12.8). Sub-fraction E12.1 (50.0 mg) was chromatographed over a silica gel column and eluted with CHCl 3 -MeOH (30:1) to obtain compound 3 (40.0 mg). Sub-fraction E12.3 (25.0 mg) was chromatographed over a silica gel column and eluted with CHCl 3 100% to obtain compound 4 (6.2 mg).
Cytotoxic activity: The cytotoxic activity assay was carried out using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay according to Mosmann. MCF-7, Hela, and HL-60 cells were cultured in Dulbecco's modified Eagle's medium (DMEM)/F-12 with 15 mM HEPES buffer, ʟ-glutamine, and pyridoxine hydrochloride supplemented with 10% fetal bovine serum and 1% penicillin-streptomycin in a 96-well plate at a density of 6 × 10 4 cells/mL. After reaching confluence (2 × 10 5 cells/mL), the cells were treated with the compounds. The compounds were dissolved in dimethylsulfoxide (DMSO) and the final concentration of DMSO was 0.1%, v/v. Different concentrations of the compounds were prepared with serial dilutions. DMSO (0.1%) was used a control. The experiment was allowed to proceed for 48 h at 37°C in a humidified 5% CO 2 atmosphere. At the end of this period, supernatants were discarded. To minimize the interference of supernatant residue, the adherent cells were washed twice with Dulbecco's phosphate buffered saline (DPBS), and then 20 µL of MTT stock solution (5 mg/mL) was added to each well and the plates were further incubated for 3 h at 37°C. DMSO (100 µL) was added to each well to solubilize the water-insoluble purple formazan crystals. After 1 h, the absorbance was measured at 570 nm with a microplate reader. Adriamycin was used as a commercial standard anticancer agent. The 50% reduction in cell number relative to the control or IC 50 was estimated visually. Values are expressed as mean ± SD.
